Peptide record

TPDB14809

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
62 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB14809
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
dbAMP DRAMP Peptipedia Antifp Antifungipept
standard
No
A 62-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from dbAMP, DRAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
NRWYCNSAAGGVGGAAGCVLAGYVGEAKENIAGEVRKGWGMAGGFTHNKACKSFPGSGWASG
Physicochemical Analysis
C269H403N81O80S4
DQ
G
6179.89
9.04
7
3
24
+3
2.61
-0.177
47.42
Mammalian: 1.4 hour Yeast: 3 min E.coli: >10 hour
19605
317.24
14
Residue Composition
number
10
A
2
R
4
N
0
D
3
C
3
E
0
Q
15
G
1
H
1
I
1
L
4
K
1
M
2
F
1
P
4
S
1
T
3
W
2
Y
4
V
Amino Acid Distribution
A: 10 R: 2 N: 4 D: 0 C: 3 E: 3 Q: 0 G: 15 H: 1 I: 1 L: 1 K: 4 M: 1 F: 2 P: 1 S: 4 T: 1 W: 3 Y: 2 V: 4
Chemical Descriptors
62
C269H403N81O80S4
6179.89
9.04
+3
2.61
-0.177
Evidence Records 48 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.2-0.4 µg/mL

Target

S. enteritidis strains

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar
Evidence 2 Activity

Activity

MIC
Antibacterial
0.4 µg/mL

Target

S. choleraesuis

Source & Reference

dbAMP DRAMP

Other

Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six
Evidence 3 Activity

Activity

MIC
Antibacterial
0.2-0.4 µg/mL

Target

S. typhimurium

Source & Reference

dbAMP DRAMP

Other

h of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6
Evidence 4 Activity

Activity

MIC
Antibacterial
0.4 µg/mL

Target

S. enterica serovar Gallinarum

Source & Reference

dbAMP DRAMP

Other

(MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.
Evidence 5 Activity

Activity

MIC
Antibacterial
0.1 µg/mL

Target

Y. enterocolitica strains

Source & Reference

dbAMP DRAMP

Other

erovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3
Evidence 6 Activity

Activity

MIC
Antibacterial
3.2 µg/mL

Target

Y. pseudotuberculosis

Source & Reference

dbAMP DRAMP

Other

oli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/m
Evidence 7 Activity

Activity

MIC
Antibacterial
1.6 µg/mL

Target

Citrobacter freundii

Source & Reference

dbAMP DRAMP

Other

, three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/
Evidence 8 Activity

Activity

MIC
Antibacterial
3.2 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP

Other

ains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epider
Evidence 9 Activity

Activity

MIC
Antibacterial
0.1 µg/mL

Target

S. dysenteriae

Source & Reference

dbAMP DRAMP

Other

tuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocy
Evidence 10 Activity

Activity

MIC
Antibacterial
0.1 µg/mL

Target

C. jejuni L4

Source & Reference

dbAMP DRAMP

Other

freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml),
Evidence 11 Activity

Activity

MIC
Antibacterial
1.6 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC
Evidence 12 Activity

Activity

MIC
Antibacterial
0.1 µg/mL

Target

L. monocytogenes 9-72

Source & Reference

dbAMP DRAMP

Other

.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC 0.05-1.6 ug/ml in Table 1 in ref). Pept
Evidence 13 Activity

Activity

MIC
Antifungal
0.2-0.4 µg/mL

Target

S. enteritidis strains

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar
Evidence 14 Activity

Activity

MIC
Antifungal
0.4 µg/mL

Target

S. choleraesuis

Source & Reference

dbAMP DRAMP Antifungipept

Other

Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six
Evidence 15 Activity

Activity

MIC
Antifungal
0.2-0.4 µg/mL

Target

S. typhimurium

Source & Reference

dbAMP DRAMP Antifungipept

Other

h of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6
Evidence 16 Activity

Activity

MIC
Antifungal
0.4 µg/mL

Target

S. enterica serovar Gallinarum

Source & Reference

dbAMP DRAMP Antifungipept

Other

(MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.
Evidence 17 Activity

Activity

MIC
Antifungal
0.1 µg/mL

Target

Y. enterocolitica strains

Source & Reference

dbAMP DRAMP Antifungipept

Other

erovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3
Evidence 18 Activity

Activity

MIC
Antifungal
3.2 µg/mL

Target

Y. pseudotuberculosis

Source & Reference

dbAMP DRAMP Antifungipept

Other

oli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/m
Evidence 19 Activity

Activity

MIC
Antifungal
1.6 µg/mL

Target

Citrobacter freundii

Source & Reference

dbAMP DRAMP Antifungipept

Other

, three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/
Evidence 20 Activity

Activity

MIC
Antifungal
3.2 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

dbAMP DRAMP Antifungipept

Other

ains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epider
Evidence 21 Activity

Activity

MIC
Antifungal
0.1 µg/mL

Target

S. dysenteriae

Source & Reference

dbAMP DRAMP Antifungipept

Other

tuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocy
Evidence 22 Activity

Activity

MIC
Antifungal
0.1 µg/mL

Target

C. jejuni L4

Source & Reference

dbAMP DRAMP Antifungipept

Other

freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml),
Evidence 23 Activity

Activity

MIC
Antifungal
1.6 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP Antifungipept

Other

.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC
Evidence 24 Activity

Activity

MIC
Antifungal
0.1 µg/mL

Target

L. monocytogenes 9-72

Source & Reference

dbAMP DRAMP Antifungipept

Other

.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC 0.05-1.6 ug/ml in Table 1 in ref). Pept
Evidence 25 Activity

Activity

MIC
Antiparasitic
0.2-0.4 µg/mL

Target

S. enteritidis strains

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar
Evidence 26 Activity

Activity

MIC
Antiparasitic
0.4 µg/mL

Target

S. choleraesuis

Source & Reference

DRAMP

Other

Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six
Evidence 27 Activity

Activity

MIC
Antiparasitic
0.2-0.4 µg/mL

Target

S. typhimurium

Source & Reference

DRAMP

Other

h of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6
Evidence 28 Activity

Activity

MIC
Antiparasitic
0.4 µg/mL

Target

S. enterica serovar Gallinarum

Source & Reference

DRAMP

Other

(MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.
Evidence 29 Activity

Activity

MIC
Antiparasitic
0.1 µg/mL

Target

Y. enterocolitica strains

Source & Reference

DRAMP

Other

erovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3
Evidence 30 Activity

Activity

MIC
Antiparasitic
3.2 µg/mL

Target

Y. pseudotuberculosis

Source & Reference

DRAMP

Other

oli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/m
Evidence 31 Activity

Activity

MIC
Antiparasitic
1.6 µg/mL

Target

Citrobacter freundii

Source & Reference

DRAMP

Other

, three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/
Evidence 32 Activity

Activity

MIC
Antiparasitic
3.2 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

DRAMP

Other

ains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epider
Evidence 33 Activity

Activity

MIC
Antiparasitic
0.1 µg/mL

Target

S. dysenteriae

Source & Reference

DRAMP

Other

tuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocy
Evidence 34 Activity

Activity

MIC
Antiparasitic
0.1 µg/mL

Target

C. jejuni L4

Source & Reference

DRAMP

Other

freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml),
Evidence 35 Activity

Activity

MIC
Antiparasitic
1.6 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

DRAMP

Other

.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC
Evidence 36 Activity

Activity

MIC
Antiparasitic
0.1 µg/mL

Target

L. monocytogenes 9-72

Source & Reference

DRAMP

Other

.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC 0.05-1.6 ug/ml in Table 1 in ref). Pept
Evidence 37 Activity

Activity

MIC
Antiviral
0.2-0.4 µg/mL

Target

S. enteritidis strains

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar
Evidence 38 Activity

Activity

MIC
Antiviral
0.4 µg/mL

Target

S. choleraesuis

Source & Reference

DRAMP

Other

Spot test: It inhibits the growth of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six
Evidence 39 Activity

Activity

MIC
Antiviral
0.2-0.4 µg/mL

Target

S. typhimurium

Source & Reference

DRAMP

Other

h of Gram- 4 S. enteritidis strains (MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6
Evidence 40 Activity

Activity

MIC
Antiviral
0.4 µg/mL

Target

S. enterica serovar Gallinarum

Source & Reference

DRAMP

Other

(MIC 0.2-0.4 ug/ml), S. choleraesuis (MIC 0.4 ug/ml), S. typhimurium (MIC 0.2-0.4 ug/ml), S. enterica serovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.
Evidence 41 Activity

Activity

MIC
Antiviral
0.1 µg/mL

Target

Y. enterocolitica strains

Source & Reference

DRAMP

Other

erovar Gallinarum (MIC 0.4 ug/ml), six E. coli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3
Evidence 42 Activity

Activity

MIC
Antiviral
3.2 µg/mL

Target

Y. pseudotuberculosis

Source & Reference

DRAMP

Other

oli strains O157:H7 (MIC 0.1-1.6 ug/ml), three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/m
Evidence 43 Activity

Activity

MIC
Antiviral
1.6 µg/mL

Target

Citrobacter freundii

Source & Reference

DRAMP

Other

, three Y. enterocolitica strains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/
Evidence 44 Activity

Activity

MIC
Antiviral
3.2 µg/mL

Target

Klebsiella pneumoniae

Source & Reference

DRAMP

Other

ains (MIC 0.1 ug/ml), Y. pseudotuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epider
Evidence 45 Activity

Activity

MIC
Antiviral
0.1 µg/mL

Target

S. dysenteriae

Source & Reference

DRAMP

Other

tuberculosis (MIC 3.2 ug/ml), C. freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocy
Evidence 46 Activity

Activity

MIC
Antiviral
0.1 µg/mL

Target

C. jejuni L4

Source & Reference

DRAMP

Other

freundii (MIC 1.6 ug/ml), K. pneumoniae (MIC 3.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml),
Evidence 47 Activity

Activity

MIC
Antiviral
1.6 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

DRAMP

Other

.2 ug/ml), S. dysenteriae (MIC 0.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC
Evidence 48 Activity

Activity

MIC
Antiviral
0.1 µg/mL

Target

L. monocytogenes 9-72

Source & Reference

DRAMP

Other

.1 ug/ml), C. jejuni L4 (MIC 0.1 ug/ml), Gram+ S. aureus, S. epidermidis (MIC 1.6 ug/ml), L. monocytogenes 9-72 (MIC 0.1 ug/ml), and 20 other Campylobacter species isolates (MIC 0.05-1.6 ug/ml in Table 1 in ref). Pept